Lilly Nets Another 2nd Circ. Win In Zyprexa MDL

Law360, New York (September 27, 2012, 7:35 PM EDT) -- The Second Circuit on Wednesday affirmed a victory for Eli Lilly & Co. in a suit in multidistrict litigation claiming it failed to warn of diabetes risks associated with its antipsychotic drug Zyprexa, saying a man's physician continued to prescribe the drug after the company sent out warning letters.

In a nonprecedential decision, a three-judge panel upheld a summary judgment ruling in favor of Lilly. The suit was one of a handful remaining in the multidistrict litigation over Zyprexa after the drugmaker paid out $1.2 billion...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.